According to an independent U.S. lab report, high levels of the cancer-causing chemical benzene have been identified in certain acne treatments, including products from Estee Lauder’s Clinique, Target’s Up & Up, and Clearasil owned by Reckitt Benckiser. The U.S.-based independent laboratory Valisure has filed a petition with the U.S. Food and Drug Administration (FDA), urging...
Tag: <span>Cancer</span>
Post
Researchers Uncover How Gene Traits Are Passed On
Understanding how this coupled mechanism could lead to new treatments for cancer and other epigenetic diseases. the University of Hong Kong Credit: iStock. A research team led by Professor Yuanliang ZHAI at the School of Biological Sciences, The University of Hong Kong (HKU) collaborating with Professor Ning GAO and Professor Qing LI from Peking University...
Post
‘Double life’ of key immune protein reveals new strategies for treating cancer and autoimmune diseases
by NYU Langone Health Credit: CC0 Public DomainInsights into the workings of an immune cell surface receptor, called PD-1, reveal how treatments that restrict its action can potentially be strengthened to improve their anticancer effect, a new study shows. The same findings also support experimental treatment strategies for autoimmune diseases, in which the immune system...
Post
Study finds worsening metabolic syndrome increases the risk of developing cancer
by Wiley Credit: Pavel Danilyuk from PexelsNew research indicates that individuals with persistent and worsening metabolic syndrome—which encompasses conditions such as high blood pressure, elevated blood sugar, excess abdominal fat, and abnormal cholesterol—face an elevated risk of developing various types of cancer. The findings are published in a paper titled “The association of metabolic syndrome...
Post
Researchers invent a new class of AI to improve cancer research and treatments
by Colette Gallagher, Mayo Clinic Credit: Mayo ClinicMayo Clinic researchers recently invented a new class of artificial intelligence (AI) algorithms called hypothesis-driven AI that are a significant departure from traditional AI models which learn solely from data. In a review published in Cancers, the researchers note that this emerging class of AI offers an innovative...
Post
Lung cancer treatment shows promise in tumor models
by UT Southwestern Medical Center 6TdG induces double stranded breaks and apoptosis in mouse tumors. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-44861-8A molecule has demonstrated its ability to kill tumor cells and incite an immune response in preclinical models of small cell lung cancer (SCLC), according to UT Southwestern Medical Center researchers. The findings, published in...
Post
Study finds calcium, vitamin D supplements may reduce cancer mortality in long term
by Elana Gotkine For postmenopausal women, calcium and vitamin D (CaD) supplements may reduce cancer mortality and increase cardiovascular disease (CVD) mortality after more than 20 years of follow-up, according to a study published online March 12 in the Annals of Internal Medicine. Cynthia A. Thomson, Ph.D., R.D., from the Mel and Enid Zuckerman College...
Post
Protein ‘brake’ could help develop new cancer treatments
by Stanford University Credit: Pixabay/CC0 Public DomainSome cancerous tumors hijack proteins that act as “brakes” on our immune system and use them to form a sort of shield against immune recognition. Immunotherapy treatments have been created that turn off these “brakes” and allow our body to attack foreign-looking cancer cells. To further advance such treatments,...
Post
New experimental pill that spots tumors YEARS before they develop could prevent ‘death sentence’ form of cancer
Patients diagnosed with esophageal cancer have low chances of survivalBut a test could detect signs of the cancer before it develops allowing treatment A vitamin pill-sized device could revolutionize the battle against a deadly throat cancer by diagnosing patients before they develop the disease. Patients diagnosed with esophageal cancer have just a 50 percent chance...
Post
‘Switchable’ Bispecific Antibodies Pave Way for Safer Cancer Treatment
Immunotherapy utilizing an FDA-approved drug has enabled Penn researchers to develop a novel switchable bispecific T cell engager that mitigates negative outcomes of immunotherapy.Taking a blood sample – illustrative photo. Image credit: Annett Klingner via Pixabay, free license In the ever-evolving battle against cancer, immunotherapy presents a turning point. It began with harnessing the body’s...